SELLAS Life Sciences Group, Inc. - Common Stock (SLS)

CUSIP: 81642T209

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
152,677,102
Total 13F shares
1,733,782
Share change
-125,488
Total reported value
$9,586,000
Put/Call ratio
30%
Price per share
$5.53
Number of holders
26
Value change
-$1,340,161
Number of buys
10
Number of sells
16

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 81642T209?
CUSIP 81642T209 identifies SLS - SELLAS Life Sciences Group, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SLS - SELLAS Life Sciences Group, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
0.43%
651,283
$5,966,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
0.17%
252,838
$2,315,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
0.12%
184,868
$1,694,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.09%
133,801
$1,225,000 30 Sep 2021
13F
BANK OF MONTREAL /CAN/
13F
Company
0.07%
110,192
$1,080,000 30 Sep 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.07%
112,866
$1,034,000 30 Sep 2021
13F
Equitable Holdings, Inc.
13F
Company
0.07%
100,000
$916,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.03%
43,891
$403,000 30 Sep 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
42,489
$389,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
0.02%
37,468
$343,000 30 Sep 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0.02%
29,921
$274,000 30 Sep 2021
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.02%
28,380
$260,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
0.02%
24,605
$225,000 30 Sep 2021
13F
Bank of New York Mellon Corp
13F
Company
0.01%
20,977
$192,000 30 Sep 2021
13F
JANE STREET GROUP, LLC
13F
Company
0.01%
20,367
$186,000 30 Sep 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.01%
15,924
$146,000 30 Sep 2021
13F
Jump Financial, LLC
13F
Company
0.01%
14,627
$134,000 30 Sep 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.01%
12,161
$111,000 30 Sep 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.01%
10,700
$98,000 30 Sep 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
4,097
$37,000 30 Sep 2021
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
3,090
$28,000 30 Sep 2021
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
2,075
$19,000 30 Sep 2021
13F
Global Retirement Partners, LLC
13F
Company
0%
1,000
$9,000 30 Sep 2021
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0%
704
$6,000 30 Sep 2021
13F
ROYAL BANK OF CANADA
13F
Company
0%
500
$5,000 30 Sep 2021
13F
HARBOUR INVESTMENTS, INC.
13F
Company
0%
200
$2,000 30 Sep 2021
13F
Cutler Group LLC / CA
13F
Company
0%
200
$1,000 30 Sep 2021
13F
Allworth Financial LP
13F
Company
0%
150
$1,000 30 Sep 2021
13F
FMR LLC
13F
Company
0%
96
$1,000 30 Sep 2021
13F

Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) as of Q4 2021

As of 31 Dec 2021, SELLAS Life Sciences Group, Inc. - Common Stock (SLS) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,733,782 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Equitable Holdings, Inc., AMERIPRISE FINANCIAL INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, STATE STREET CORP, and BANK OF AMERICA CORP /DE/. This page lists 26 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
29
Q4 2021 holders
26
Holder diff
-3
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.